Your browser doesn't support javascript.
loading
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib.
Vidarsdottir, Linda; Fernandes, Rita Valador; Zachariadis, Vasilios; Das, Ishani; Edsbäcker, Elin; Sigvaldadottir, Ingibjorg; Azimi, Alireza; Höiom, Veronica; Hansson, Johan; Grandér, Dan; Egyházi Brage, Suzanne; Pokrovskaja Tamm, Katja.
Afiliación
  • Vidarsdottir L; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Fernandes RV; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Zachariadis V; Present address: Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Das I; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Edsbäcker E; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Sigvaldadottir I; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Azimi A; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Höiom V; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Hansson J; Present address: Department of Immunology, Genetics and Pathology, BMC, Uppsala University, Uppsala, Sweden.
  • Grandér D; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Egyházi Brage S; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
  • Pokrovskaja Tamm K; Department of Oncology and Pathology, Karolinska Institutet, Bioclinicum, Solna.
Melanoma Res ; 30(5): 443-454, 2020 10.
Article en En | MEDLINE | ID: mdl-32467529
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN sin Sentido / Proteína beta Potenciadora de Unión a CCAAT / Vemurafenib / Melanoma Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN sin Sentido / Proteína beta Potenciadora de Unión a CCAAT / Vemurafenib / Melanoma Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido